Evercyte - the pharmacocellomicsTM company.
Vision
Acceleration of drug finding and development by reduction of development time and cost by introducing panels of immortalized human cell strains for drug screening strategies.
Evercyte will establish the new concept of “pharmacocellomicsTM” in the field of pre-clinical developments.
Therefore, we will provide primary cells from different patients and tissues that are immortalized by telomerase or other strategies (SV40; SNEV) that we have established. Thus we guarantee cell strains with the most similar phenotype to the primary cells in sufficient amounts to perform reproducible preclinical drug testing. We will deliver (i) single immortalized cell strains including mesenchymal stem cells that can be differentiated to the cell type of interest; (ii) cell panels including sufficient cell strains of different tissues and/or donors of different status (healthy, diseased, young, old, etc) in order to generate statistically meaningful data that allow to estimate drug efficiencies and toxicity with high predictive power. Finally, (iii) we will establish customer-tailored immortalized cell strains according to the needs of specific customers.
Company Details
- Employees
- 8
- Founded
- -
- Address
- Leberstraße, 20,austria
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- evercyte.com
- Keywords
- immortalized cell lines for pharma and cosmetic industry, cell models, telomerase, induced pluripotent stem cells, immortalized cell lines, lifespan extended cell lines, drug development, in vitro toxicology testing.
- HQ
- Wien
Evercyte Gmbh Questions
Evercyte Gmbh's website is evercyte.com
Evercyte Gmbh's LinkedIn profile is https://at.linkedin.com/company/evercyte
Evercyte Gmbh has
8 employees.
View email and phone details for 8
employees at Evercyte Gmbh.
Evercyte Gmbh's industry is
Biotechnology Research
Evercyte Gmbh's top competitors are
Tamirna Gmbh,
Lexogen,
Ribbon Bio,
Bit.bio Discovery,
Hookipa Pharma Inc.,
Oncoone,
Proxygen,
Valanx Biotech,
Apeiron Biologics Ag,
Myllia Biotechnology.
Evercyte Gmbh's categories are Biotechnology Research
Evercyte Gmbh's founding year is 2011
